Literature DB >> 9403903

IQ and risk for schizophrenia: a population-based cohort study.

A S David1, A Malmberg, L Brandt, P Allebeck, G Lewis.   

Abstract

BACKGROUND: This study aimed to quantify the association between low IQ and the later development of psychosis in a population-based cohort study of 18-year-old conscripts.
METHODS: Fifty thousand males conscripted into the Swedish army in 1969-1970 were followed by means of the Swedish National Register of Psychiatric Care up to 1983. Tests of verbal and visuospatial abilities, general and mechanical knowledge and several psychosocial variables were recorded at conscription.
RESULTS: One hundred and ninety-five subjects were admitted to hospital with schizophrenia and 192 with a non-schizophrenic psychosis on ICD-8 criteria. The distribution of scores in those later diagnosed as suffering from schizophrenia was shifted in a downward direction, with a linear relationship between low IQ and risk. This remained after adjustment for potential confounders. The risk for non-schizophrenic disorders was also higher in those with lower IQ but the effect was less marked and non-linear. Only poorer performance on the verbal tasks and mechanical knowledge test conferred a significantly increased risk for schizophrenia after taking into account general intellectual ability. Low IQ at conscription was not related to age of onset.
CONCLUSIONS: The results confirm the importance of low intellectual ability as a risk factor for schizophrenia and other psychoses. This is unlikely to be due to prodromal decline or known confounders. The association could be directly causal with cognitive impairment leading to false beliefs and perceptions, or could be indirect with any factors causing lower IQ, such as abnormal brain development increasing the risk for schizophrenia.

Entities:  

Mesh:

Year:  1997        PMID: 9403903     DOI: 10.1017/s0033291797005680

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  96 in total

1.  Patterns of dysmorphic features in schizophrenia.

Authors:  L E Scutt; E W Chow; R Weksberg; W G Honer; A S Bassett
Journal:  Am J Med Genet       Date:  2001-12-08

2.  Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.

Authors:  Stanley Zammit; Peter Allebeck; Sven Andreasson; Ingvar Lundberg; Glyn Lewis
Journal:  BMJ       Date:  2002-11-23

3.  Intelligence level in late adolescence is inversely associated with BMI change during 22 years of follow-up: results from the WICTORY study.

Authors:  Andreas Rosenblad; Göran Nilsson; Jerzy Leppert
Journal:  Eur J Epidemiol       Date:  2012-07-10       Impact factor: 8.082

Review 4.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

5.  Early risk factors for criminal offending in schizophrenia: a 35-year longitudinal cohort study.

Authors:  Asa Eriksson; Anders Romelsjö; Marlene Stenbacka; Anders Tengström
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-07-04       Impact factor: 4.328

6.  Neurocognitive profile in 22q11 deletion syndrome and schizophrenia.

Authors:  Eva W C Chow; Mark Watson; Donald A Young; Anne S Bassett
Journal:  Schizophr Res       Date:  2006-06-06       Impact factor: 4.939

7.  Low intelligence test scores in 18 year old men and risk of suicide: cohort study.

Authors:  D Gunnell; P K E Magnusson; F Rasmussen
Journal:  BMJ       Date:  2004-12-22

8.  Premorbid neurocognitive functioning in schizophrenia spectrum disorder.

Authors:  Holger J Sørensen; Erik L Mortensen; Josef Parnas; Sarnoff A Mednick
Journal:  Schizophr Bull       Date:  2006-01-25       Impact factor: 9.306

9.  Clinical implications of cognitive function in bipolar disorder.

Authors:  C T Sudhir Kumar; Sophia Frangou
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

10.  Academic attainment: a predictor of psychiatric disorders?

Authors:  Siow Ann Chong; Mythily Subramaniam; I-Min Lee; Elaine Pek; Christopher Cheok; Swapna Verma; John Wong
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-18       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.